GWS
ANIP icon

Glassman Wealth Services’s ANI Pharmaceuticals ANIP Stock Holding History

Glassman Wealth Services’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-50
Closed -$1K – 1651
2022
Q1 		$1K Buy
+50
New +$1.86K ﹤0.01% 1317

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $486M AUM 50.29% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return

Glassman Wealth Services's ANIP Position: Q2 2022 in Review

Glassman Wealth Services sold out of ANI Pharmaceuticals (ANIP) in Q2 2022, closing a stake of 50 shares — an estimated $1K sold.

Glassman Wealth Services first reported a position in ANIP in Q1 2022 and held it in 1 quarter. The position peaked at $1K in Q1 2022. 120 funds tracked by Wall St. Rank hold ANIP as of Q2 2022.

  • Glassman Wealth Services reported no remaining ANI Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Glassman Wealth Services sold 50 ANI Pharmaceuticals shares in Q2 2022, an estimated $1K.
  • Glassman Wealth Services first reported a position in ANI Pharmaceuticals in Q1 2022 and held it in 1 quarter.
  • Glassman Wealth Services's ANI Pharmaceuticals position peaked at $1K in Q1 2022.
  • 120 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2022.

Based on Glassman Wealth Services's 13F filing for Q2 2022, filed 4 Aug 2022.